- Human-data-first genomics discovery for healthcare buyers
- Focused on precision medicine teams, rather than generic AI
- Suitable for organization-wide healthcare rollouts
Verge Genomics
Human-data-first genomics drug discovery
SF7.1
SF Score editorial score across features, ease, and value, based on public reviews and product research. Learn more →
Support precision oncology workflowsNeuroscience and discovery research teams
Support precision oncology workflowsNeuroscience and discovery research teams
Best for
Neuroscience and discovery research teams
Pricing
Custom
SoftFinders Score
7.1 / 10
Overview
What is Verge Genomics?
Verge Genomics is an AI drug discovery company using human genomics to identify targets for neurodegenerative and complex diseases for neuroscience research teams.
- Core focus: The platform centers on genomic interpretation and precision care support rather than standalone test results, while clinical context remains essential to care decisions.
- Buyer fit: Its clearest fit is neuroscience and discovery research teams seeking drug discovery grounded in human genomics.
- Implementation checks: Buyers should confirm test menu, turnaround time, EHR result delivery, clinical interpretation, validation depth, coverage, and rollout plans before adoption.
- Commercial model: Engagement is pipeline and partnership led, while pricing is sales led and scoped rather than posted publicly.
Overall, Verge Genomics fits precision medicine programs that can accommodate clinical interpretation and a partnership driven buying process.
KEY FEATURES
What you get out of the box
Clinical Trials
Connects insights with clinical trial options
Precision Care
Supports precision care workflows across patients
Data Platform
Unified clinico-molecular data platform
Reporting Tools
Reports genomic findings for care teams
Genomic Interpretation
Interprets genomic test results in context
Multiomics Analysis
Analyzes multiple omics data layers together
USE CASES
Where teams put it to work
Support precision oncology workflows
Bridge genomic data and clinical trials
Interpret genomic test results in context
Support early cancer detection programs
Surface biomarker signals across data
Connect genomic insights with care decisions
Editorial Take
What we like, and what to verify
- Engagement is pipeline and partnership-led
- Clinical interpretation required for every result
- Pricing is sales-led and requires upfront scoping
Screenshots
A look inside
Alternatives
Tools to consider next
Deep Genomics SF 7.1
Why consider it
AI for RNA biology and targets
Inflammatix SF 7.2
Why consider it
Gene-signature readouts for infection testing
Variantyx SF 7
Why consider it
Whole-genome analytics for clinical diagnosis
Genome Medical SF 7.1
Why consider it
Tech-enabled genetic counseling and testing network
Sully.ai SF 7.6
Why consider it
All-in-one AI scribe and clinician assistant
Tali AI SF 7.5
Why consider it
Voice AI scribe with built-in medical search
FAQ